Wiklund, Olov

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group

Langlois, M. R., Descamps, O. S., van der Laarse, A., Weykamp, C., Baum, H., Pulkki, K., von Eckardstein, A., De Bacquer, D., Borén, J., Wiklund, O., et al. (2014) · Atherosclerosis

Clinical Laboratory Practices and Quality ControlLipoproteins and Cardiovascular Health

Cited by 72

Cholesterol Reduction and Clinical Benefit: Are There Limits to Our Expectations?

Fager, G., & Wiklund, O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 62

Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy

Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Current Cardiology Reports

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 45